Breast Augmentation in Saint Louis Missouri
Breast Augmentation in Saint Louis section, includes general infrmation about Breast Augmentation Procedure, Breast Augmentation Saint Louis Local News, Breast Augmentation Saint Louis Surgeon Locator and other Breast Augmentation related material.
Saint Louis Breast Augmentation - The plastic surgery procedure
The operation is usually done when the breast reaches its final size after puberty (ages 17-18). Except for cases when there is congenital breast hypoplasia or breast asymmetry in which it can be done earlier.
Saint Louis breast augmentation - The implants
There are three possible sites for the insertion of an implant. The lower fold of the breast is the most common site. It allows full excess and lives a hidden scar. The second site is through the areola. This incision gives the best esthetic results but it is also the only one that goes through the breast tissue therefore the risk of infection and sensation loss is higher. The third one is through the armpits. Some surgeons prefer it because the scar is almost invisible (except for those women who like to wear open close with no sleeves(. The disadvantage of this incision is a slight asymmetry of the breast. The decision usually made individually with each woman and the surgeon.
Saint Louis breast augmentation - Insertion locations
The implant can be inserted above or below the chest muscles. The below position considered to be more preferable by most surgeons. There is less chance of feeling the implant, less chance of developing irregular folds or bumps on the surface of the breast and the implant is less likely to drop. This kind of technique is suitable for women with relatively little extra skin and less fallen breasts.
Most of the implants are made of silicon, and since the FDA determined that they safe for use they are being widely used by most Saint Louis surgeons.
Saint Louis breast augmentation - Shape and Size
The implants come in two shapes: round and pear shape also called "anatomic implants" because their shape resembles the natural contour of the breast. They are more expensive and require larger excision.
The size of an implant usually depends on the woman size and proportions, the average size is 300cc. It is believed that smaller implants have lower complications.
Saint Louis - breast augmentation - After The Plastic Surgery
After the surgery you'll be wearing a sports bra or a bandage. You'll continue wearing them at all times day and night for about a month. You'll be able to take a shower 24 hours after the surgery. The most optimal results usually seen 3 month after the surgery. Several things can complicate this procedure; those are rare complications, which you should be aware off. Bleeding around the area of the implant, infection, disturbances of sensation and touch around the nipples, silicon leak, rejection off an implant and some degree of irregularity on the surface of an implant.
Other Breast Augmentation Procedures
All Breast Procedures
Breast Augmentation saint-louis (current)
saint-louis Breast Lift
saint-louis Breast Implants
saint-louis Implant Removal
saint-louis Armpit Incision
More Saint Louis info...
Breast AugmentationLatest Forum Posts...
- Just wondering if anyone would like to discuss their experiences with textured implants; it's not all that popular, it seems in Canada.
Plastic Surgery News...
- Commenting on a Which survey that asked patients about their health priorities, Dr Laurence Buckman, chairman of the BMA's GPs Committee said: "GPs will always do their best to ensure that all their patients are able to get an appointment when they need one. If anyone is asked if they would like more of a good thing, I understand why they say 'yes'.
- Data presented at the American Society of Clinical Oncology meeting suggest that 15% of patients who took sunitinib (Sutent®) developed heart failure. Researchers studied 48 patients with kidney cancer or gastrointestinal stromal tumor (GIST) on sunitinib and noted that 7 (15%) experienced heart failure. The problems began between 22 days and 435 days after beginning therapy, although most started within the first three months of treatment. Individuals with a history of heart failure, coronary artery disease or low BMI were at an even higher risk and 3 of 5 patients followed long term continued to have heart problems even after the drug was stopped. The researchers call for routine cardiac monitoring in patients receiving sunitinib and for cardiac adverse effects to be carefully examined in future trials of the drug. Previously, a retrospective analysis of phase I/II data published in the Lancet had noted the development of cardiovascular adverse events, including heart failure, in some patients with GIST who took the drug (see NeLM link). At the time of the Lancet paper, Pfizer released a statement agreeing that these cardiac risks do exist but added that they "were medically manageable in most patients and underscore the importance of having a collaborative team of health-care professionals working together to appropriately manage patients who have limited available options" in treating their cancer.